Analyst Ratings and Price Targets for BioAtla on NASDAQ
BioAtla, a company listed on the NASDAQ under the ticker symbol BCAB, has recently received ratings from a group of ...
Tag: BCAB
JP Morgan Analyst Maintains Positive Outlook on BioAtla with Revised Price Target
On September 25, 2023, JP Morgan analyst Brian Cheng expressed his positive outlook on BioAtla (NASDAQ:BCAB) by maintaining an Overweight ...
BioAtla, Inc. Rated ‘Moderate Buy’ by Analysts: A Promising Player in the Biopharmaceutical Industry
On August 31, 2023, BioAtla, Inc. (NASDAQ: BCAB) was given a rating of "Moderate Buy" by six ratings firms, according ...
Connor Clark & Lunn Investment Management Ltd. Acquires Stake in BioAtla, Inc: Confidence in Biopharmaceutical Potential
On August 29, 2023, it was reported that Connor Clark & Lunn Investment Management Ltd. acquired a new stake in ...
Uncovering the Promising Potential of BioAtla: A Rising Star in Biopharmaceuticals
In the ever-evolving world of biopharmaceuticals, companies like BioAtla are capturing the attention of investors and analysts alike. On August ...
BioAtla Inc.: Pioneering Precision Medicine in Cancer Treatment
In the ever-evolving field of biopharmaceuticals, BioAtla Inc. (NASDAQ: BCAB) stands out with its latest analysis and groundbreaking advancements. On ...
BioAtla Receives Overweight Rating from JP Morgan Analyst
As of August 2, 2023, BioAtla (NASDAQ: BCAB) has received an Overweight rating from JP Morgan analyst Brian Cheng. Although ...
BioAtla Receives Positive Outlook with Adjusted Price Target
On August 2, 2023, JMP Securities analyst Reni Benjamin expressed his outlook on BioAtla (NASDAQ:BCAB), reaffirming a positive Market Outperform ...
Analyst Reaffirms Positive Outlook on BioAtla with 25 Price Target
On August 2, 2023, Tony Butler, an analyst at EF Hutton, reaffirmed his positive outlook on BioAtla (NASDAQ:BCAB) by reiterating ...
BioAtla Reports Q2 Financial Performance and Maintains Strong Cash Balance
On August 1, 2023, BioAtla, a renowned biopharmaceutical company, unveiled its financial performance for the second quarter ending June 30, ...